ERAS-4001 — Initial data
H2 2026
Additional ERAS-0015 monotherapy and combination data expected in H1 2027; ERAS-4001 Phase 1 preliminary monotherapy data expected in H2 2026Source filing
ERAS biotech catalysts & pipeline
ERASCA INC · Data as of 2026-10-25
Upcoming catalysts
ERAS-0015 — Interim data
H1 2027
Phase 1 monotherapy expansion data expected in the first half of 2027Source filing